Genetic predisposition to breast and ovarian cancer: a case study.
Information concerning genetic predisposition and the discovery of genes associated with certain cancer risks is changing rapidly. Nurses must keep abreast of these changes so that they can better understand the choices patients have and the consequences of those choices. This article discusses the issues pertinent to women with a genetic predisposition to breast or ovarian cancer, or both. Discoveries in the Human Genome Project have already begun to change traditional perspectives on screening, diagnosing, preventing, and treating cancer. These genetic discoveries hold both promise and concern for health care professionals. The promise lies in the precise identification of genetic predisposition to common diseases and the potential to prevent or reduce morbidity and mortality rates. The concern lies in issues of confidentiality and discrimination: Predicting predisposition to incurable illnesses may have substantial negative impact on the person's quality of life and psychosocial integrity.
Amlung
S
S
Institute for Nursing Research, College of Nursing, University of Cincinnati, West Chester, OH 45069, USA.
Huelsman
K
K
Skinn
B
B
D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics* / Q000451:nursing; D003219:Confidentiality; D005192:Family Health; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000451:nursing; D010375:Pedigree; D011287:Prejudice; D011788:Quality of Life; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors